Aurobindo Pharma Q2 profit seen up 15% to Rs 696 cr, operating margin may grow 110 bps News News / News 6 years ago 580 Views comments EBITDA (earnings before interest, tax, depreciation and amortisation) may increase 15.6 percent year-on-year to Rs 1,074.4 crore and margin may expand... Read more
News World Bank#39;s Jim Yong Kim says most members #39;on board#39; with capital hike News / News - 7 years ago
Comments